胰腺及壶腹部癌的微卫星不稳定:组织学、分子病理与临床意义
本文综述胰腺及壶腹部不同癌种中微卫星不稳定/错配修复缺陷(MSI/dMMR)的患病率、组织学关联及临床意义。PDAC中约1-2%,壶腹部腺癌可达18%(肠型更常见),腺泡细胞癌可达14%,神经内分泌癌可达5-8%。推荐常规评估MSI/dMMR,PDAC和壶腹部癌首选免疫组化,腺泡细胞癌和神经内分泌癌首选分子检测。
要点
- 胰腺及壶腹部不同癌种MSI/dMMR患病率差异显著,需按组织学类型选择性检测。
- PDAC和壶腹部癌首选免疫组化检测MMR蛋白,腺泡细胞癌和神经内分泌癌首选分子检测。
- MSI/dMMR对免疫治疗反应率高,应纳入常规诊断流程。
核心结论
- MSI/dMMR在胰腺及壶腹部不同癌种中具有不可忽视的患病率,应至少对最典型组织学类型纳入常规诊断评估。
研究设计与样本
- 本文为综述,汇总胰腺及壶腹部癌中MSI/dMMR的患病率、组织学关联及检测方法。
主要发现
- 胰腺导管腺癌(PDAC)中MSI/dMMR患病率约1-2%,髓样和胶样变异型最典型。
- 壶腹部腺癌中MSI/dMMR患病率高达18%,肠型亚型更常见。
- 胰腺腺泡细胞癌中MSI/dMMR患病率高达14%。
- 胰腺及壶腹部神经内分泌癌中MSI/dMMR患病率高达5-8%,混合性神经内分泌-非神经内分泌肿瘤也应检测。
关键数值与推荐
- PDAC和壶腹部癌检测首选免疫组化。
- 腺泡细胞癌和神经内分泌癌检测首选直接分子分析,包括基于MSI的聚合酶链反应和二代测序。
临床怎么用
- 对PDAC、壶腹部腺癌、腺泡细胞癌及神经内分泌癌应评估MSI/dMMR,以指导免疫治疗选择。
- 根据组织学类型选择检测方法:PDAC和壶腹部癌用免疫组化,腺泡细胞癌和神经内分泌癌用分子检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Microsatellite instability (MSI)/defective DNA mismatch repair (dMMR) represents an important molecular alteration with diagnostic, prognostic, and predictive value. The increasing interest toward this genetic alteration is given to the high response rate of MSI/dMMR tumors to immunotherapy. There are different cancers in the periampullary region that can harbor MSI/dMMR, and significant morphological-molecular correlates should be acknowledged in this district: (1) pancreatic ductal adenocarcinoma (PDAC): in this tumor category, the prevalence of MSI/dMMR is about 1-2%, and medullary and colloid variants are the most typically involved; (2) ampullary adenocarcinoma: here the prevalence of MSI/dMMR is up to 18%, and in this neoplastic group, MSI/dMMR is more commonly found in the intestinal subtype; (3) pancreatic acinar cell carcinoma: here the prevalence of MSI/dMMR is up to 14%; and (4) pancreatic and ampullary neuroendocrine carcinoma: in this tumor category, the prevalence of MSI/dMMR is up to 5-8%, and this molecular alteration should be assessed also in cases of mixed neuroendocrine-non-neuroendocrine neoplasms. Given the clinical importance of MSI/dMMR and its not-negligible prevalence among the different carcinomas arising in this district, its assessment should become part of the routine diagnostic workflow at least for the most typical histotypes. The test of choice is represented by immunohistochemistry for PDAC and ampullary carcinomas, and by direct molecular analyses including MSI-based polymerase chain reaction and next-generation sequencing for acinar cell and neuroendocrine carcinomas.
引用
- Luchini C, Scarpa A. Microsatellite instability in pancreatic and ampullary carcinomas: histology, molecular pathology, and clinical implications. Hum Pathol. 2022. PMID: 35714836. doi:10.1016/j.humpath.2022.06.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。